Journal of Hospital Infection, published by W B SAUNDERS CO LTD, stands as a pivotal resource in the infectious diseases, medicine, and microbiology sectors. With an impressive impact factor positioning it in the Q1 quartile across its relevant categories, this journal not only ranks highly—#32 out of 344 in Infectious Diseases and #17 out of 140 in Medical Microbiology—but also exemplifies a commitment to advancing knowledge and practice in hospital infection control. Since its inception in 1980, the journal has become a vital platform for disseminating research that informs clinical practices, promotes safety in health care environments, and enhances medical education. While access is non-open, the journal's extensive scope and rigorously peer-reviewed contributions ensure its relevance and significance to researchers, professionals, and students aiming to stay at the forefront of this dynamic field. The journal’s headquarters in London underscores its international relevance, making it an essential reference for anyone involved in combating hospital-acquired infections.

Infection and Chemotherapy, an esteemed journal published by the Korean Society of Antimicrobial Therapy, focuses on the dynamic fields of infectious diseases and pharmacology. With an ISSN of 2093-2340 and an E-ISSN of 2092-6448, this peer-reviewed, open-access journal has been providing a crucial platform for research dissemination since 2008. Based in South Korea, it boasts a significant impact in the academic community, as evidenced by its Q2 ranking in both Infectious Diseases and Pharmacology categories for 2023. It holds a Scopus rank of 64 out of 272 in Pharmacology and 98 out of 344 in Infectious Diseases, showcasing its prominence and the quality of research it publishes. With a focus on advancing scientific knowledge, Infection and Chemotherapy is committed to fostering essential dialogues among researchers, clinicians, and students, making it a vital resource for those engaged in the fight against infectious diseases and the development of effective therapeutic protocols.

The Revista Espanola de Quimioterapia, published by the SOCIEDAD ESPANOLA QUIMIOTERAPIA, is a pivotal open-access journal that has been advancing the field of clinical microbiology and pharmacology since its inception in 1989. With an E-ISSN of 1988-9518, this journal caters to a diverse audience of researchers, healthcare professionals, and students, providing them with critical insights into the latest developments in medicinal chemistry and therapeutic strategies. Located in Madrid, Spain, the journal reflects the rigorous academic standards of its associated institutions, contributing significantly to the translation of research into clinical practice. Achieving a Q3 ranking in the fields of Medicine, Microbiology, and Pharmacology in 2023 attests to its growing influence and relevance in the scientific community, making it a vital resource for those engaged in the quest for innovative solutions to pressing healthcare challenges. The journal prides itself on its commitment to maintaining an open-access model since 2018, ensuring that vital research is freely accessible to foster greater knowledge sharing and collaboration within the global scientific community.

Indian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.

Infection Prevention in Practice is a leading academic journal published by ELSEVIER that has established itself as a vital resource in the domains of Infectious Diseases and Public Health. With its Open Access policy implemented since 2019, the journal enhances global accessibility to cutting-edge research and practical insights aiming to reduce the risk of infections in various settings. It proudly holds a Q3 ranking in Infectious Diseases and a Q2 ranking in Public Health, Environmental and Occupational Health as of 2023, showcasing its impact and relevance within the scientific community—particularly with a Scopus rank placing it in the 71st percentile for public health research. Its scope includes the latest advancements, strategies, and practices in infection prevention, making it an indispensable read for researchers, healthcare professionals, and students dedicated to improving health outcomes and combating infectious diseases effectively. The journal operates from its base in the United Kingdom and reaches a global audience, fostering collaboration and innovation in infection control practices.

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

Transplant Infectious Disease is a premier journal dedicated to advancing the understanding of infectious complications in transplant recipients, contributing significantly to the fields of Infectious Diseases and Transplantation. Published by Wiley in the United Kingdom, this journal boasts an impressive reputation within the academic community, holding a 2023 Q2 quartile ranking in both Infectious Diseases and Transplantation, as well as notable Scopus rankings that position it among the top tiers of its categories. With a convergence of scholarly articles and research findings from 1999 through 2024, Transplant Infectious Disease serves as a critical resource for researchers, professionals, and students seeking to explore the intersection of transplantation and infectious diseases. The journal encourages open dialogue and knowledge dissemination through rigorous peer-reviewed content, making it an essential platform for those aiming to address the challenges and innovations in transplant medicine.

Frontiers in Cellular and Infection Microbiology, published by FRONTIERS MEDIA SA, is a leading Open Access journal that has been at the forefront of microbiological research since 2011. Located in Switzerland, this journal aims to provide a platform for innovative and impactful studies in various domains including immunology, infectious diseases, and medical microbiology. With an impressive range of quartile rankings—Q1 in Infectious Diseases, Microbiology, and Microbiology (medical), and Q2 in Immunology—as of 2023, it positions itself as a highly reputable source in the academic community. Furthermore, its Scopus rankings highlight its significance within the respective fields, with top percentiles in key categories, making it an essential resource for researchers, professionals, and students alike. As an Open Access publication, it ensures that vital findings are accessible to a global audience, fostering collaboration and advancement in science.

Infection Disease & Health, published by Elsevier Inc, serves as a premier interdisciplinary journal dedicated to advancing the fields of infectious diseases, public health, and nursing. With an impressive impact factor reflective of its rigorous scholarly contributions, the journal is currently indexed within the Q2 category in Infectious Diseases and Q1 in Nursing (miscellaneous) as of 2023, indicating its esteemed position in these areas. Launched in 2016, it has rapidly established itself as a valuable resource for researchers, clinicians, and students alike, emphasizing both original research and comprehensive reviews that address pressing health challenges. Authors and readers are encouraged to engage with a wealth of content that is meticulously curated to inform and inspire innovative practices within the health sector. While the journal is not an open-access platform, it offers various access options to enhance dissemination of knowledge. As the field of infectious diseases evolves, Infection Disease & Health remains at the forefront, fostering scholarly dialogue and contributing to the development of effective health strategies globally.

Infectious Disease Reports is a premier open-access journal published by MDPI, dedicated to advancing the field of infectious diseases. Since its inception in 2009, this journal has established itself as a significant platform for disseminating cutting-edge research, reviews, and case studies, critical for global health. With a commendable Q2 ranking in the category of Infectious Diseases and a Scopus rank of #140 out of 344, it is recognized for its impactful contributions to medical research, holding a 59th percentile in its field. The journal aims to provide comprehensive insights into various dimensions of infectious diseases, ranging from epidemiology to novel treatment modalities. As an open-access publication, Infectious Disease Reports ensures that its articles are freely available to a wide audience, fostering collaborative efforts among researchers, healthcare professionals, and students worldwide. With its ongoing commitment to excellence, the journal plays an essential role in shaping the future of infectious disease research.